2023-506305-18-01已完成1 期
An open-label, fixed sequence drug interaction study in healthy subjects to investigate the effect of multiple doses of the gastric acid-reducing agent rabeprazole on the single dose pharmacokinetics of a 40 mg deucrictiban extended-release (XR) tablet.
Pharvaris Netherlands B.V.1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2024年9月9日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trials
Scientific
Pharvaris Netherlands B.V.
研究点 (1)
Loading locations...
相似试验
已完成
不适用
An open-label, single-sequence crossover drug-drug interaction study to evaluate the effect of multiple oral doses of itraconazole on the pharmacokinetics of PHA-022121 in healthy subjectsHereditary AngioedemaNL-OMON49496Pharvaris BV14
已完成
不适用
An open-label, single-sequence cross-over drug-drug interaction study to evaluate the effect of single and multiple oral doses of PHA-022121 on the pharmacokinetics of selective CYP1A2, CYP2C19, and CYP3A4 substrates in healthy subjectsHereditary Angioedema10027664NL-OMON49587Pharvaris Netherlands BV14
未知
3 期
An open-label, add-on, drug-drug interaction study to assess the effect of FYX-051 on the pharmacokinetics and safety of warfarin in Japanese healthy adult maleHealthy adult maleJPRN-jRCT2080221293SANWA KAGAKU KENKYUSHO CO.,LTD.12
未知
3 期
An open-label, add-on, drug-drug interaction study to assess the effect of FYX-051 on the pharmacokinetics and safety of warfarin in Japanese healthy adult malejRCT2080221293SANWA KAGAKU KENKYUSHO CO.,LTD.12
未知
1 期
A clinical trial to check activity of certain enzymes in the body after taking a drug called AEB071CTRI/2009/091/000582Novartis Healthcare Pvt. Ltd.18